Ultragenyx Pharmaceutical | RARE - Ricavi Di Vendita





I Saldi Cambiamento Data
Acadia Pharmaceuticals USD 268.06M 15.94M 2026-03
Agios Pharmaceuticals USD 18.8M 1.17M 2026-03
Alnylam Pharmaceuticals USD 1.17B 70M 2026-03
BioCryst Pharmaceuticals USD 406.56M 247.16M 2025-12
BioMarin Pharmaceutical USD 766M 109M 2026-03
Esperion Therapeutics USD 168.45M 81.14M 2025-12
Insmed USD 263.8M 121.8M 2025-12
Ionis Pharmaceuticals USD 246M 43M 2026-03
Karyopharm Therapeutics USD 34.08M 3.54M 2025-12
Kyowa Hakko Kirin JPY 147.38B 28.58B 2025-12
MacroGenics USD 41.23M 31.61M 2025-12
Moderna USD 389M 289M 2026-03
Neurocrine Biosciences USD 811M 5.5M 2026-03
PTC Therapeutics USD 164.7M 46.3M 2025-12
Puma Biotechnology USD 80.54M 33.46M 2024-09
Regeneron Pharmaceuticals USD 3.6B 280M 2026-03
Sarepta Therapeutics USD 730.8M 287.9M 2026-03
Ultragenyx Pharmaceutical USD 136M 71M 2026-03
Vertex Pharmaceuticals USD 2.99B 200M 2026-03
Xoma USD 25K 5M 2024-09